NASDAQ:TECH
Bio-Techne Corp Stock News
$76.06
-1.23 (-1.59%)
At Close: May 06, 2024
MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in
Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development
07:00am, Wednesday, 14'th Apr 2021
MINNEAPOLIS, April 14, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage bi
Bio-Techne: Stealth M&A Play Looking Rich Here
12:17pm, Saturday, 10'th Apr 2021
Bio-Techne has been a steady value creator, operating largely under the radar of many investors. The company has combined organic growth with bolt-on M&A to establish this growth.
QGEN vs. TECH: Which Stock Should Value Investors Buy Now?
12:52pm, Thursday, 08'th Apr 2021
QGEN vs. TECH: Which Stock Is the Better Value Option?
Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
07:00am, Thursday, 08'th Apr 2021
MINNEAPOLIS, April 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system tha
Bio-Techne Completes Acquisition of Asuragen, Inc.
04:01pm, Tuesday, 06'th Apr 2021
MINNEAPOLIS, April 6, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc. The transaction included initial consideration of
Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results
07:00am, Tuesday, 06'th Apr 2021
MINNEAPOLIS, April 6, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, May 6, 2021, at 8:00 a.m. CDT to
Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures
07:00am, Monday, 29'th Mar 2021
MINNEAPOLIS, March 29, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract (RGF BME), an
Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
07:00am, Friday, 26'th Mar 2021
MINNEAPOLIS, March 26, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award
Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test
07:00am, Tuesday, 23'rd Mar 2021
MINNEAPOLIS, March 23, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed its clinical validation of an in vitro diag
Bio-Techne Announces ISO 9001:2015 Certification for its Bristol Manufacturing Facility.
07:00am, Monday, 15'th Mar 2021
MINNEAPOLIS, March 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagn
NEW YORK, March 10, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENX / NASDAQ: RNLX), announced today it has been named
Bio-Techne Scoops Up Genetics And Oncology-Focused Diagnostics Firm
06:37am, Thursday, 04'th Mar 2021
Bio-Techne Corp (NASDAQ: TECH) has agreed to acquire Asuragen Inc, a provider of genetic carrier screening and oncology testing kits. The deal value includes an initial consideration of $215 million
Bio-Techne to Acquire Asuragen
04:45pm, Wednesday, 03'rd Mar 2021
MINNEAPOLIS and AUSTIN, Texas, March 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research an
Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America
07:30am, Monday, 08'th Feb 2021
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE:RENX / NASDAQ: RNLX), and manufacturing partner Bio-Techne C
